Clinical Trials Logo

Filter by:
NCT ID: NCT06208163 Not yet recruiting - Abdominal Obesity Clinical Trials

The Effects of Chiropractic in a Population With High Central Adiposity

OBE
Start date: February 15, 2024
Phase: N/A
Study type: Interventional

Since 1980, the global prevalence of obesity, commonly defined as a body mass index (BMI) of 30 or higher, has doubled. Importantly, high levels of central adiposity (i.e., abdominal fat) is associated with numerous PNI-related sequelae, including increased levels of psychological distress, cognitive deficits, ANS dysfunction, and immune marker abnormalities. To our knowledge, rigorous investigation of chiropractic's impact on psychoneuroimmunological (PNI)-related outcomes in people with high central adiposity is lacking. Based on limited evidence to date, it is plausible that clinically important PNI-related dysfunctions (e.g., heightened stress levels, executive function impairments, dysautonomia, immune dysregulation) common in this population could be ameliorated via chiropractic care.

NCT ID: NCT06208124 Recruiting - Clinical trials for Non-small Cell Lung Cancer

A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors

Start date: February 27, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This is a FIH, ascending dose study to characterize the safety, tolerability, optimal dose and preliminary anti-tumor activity of IMM-6-415 in participants with advanced or metastatic solid tumors harboring RAS or RAF oncogenic mutations.

NCT ID: NCT06208085 Recruiting - Clinical trials for Breastfeeding, Exclusive

Avocado Consumption, Nutrients in Human Milk, and Infant Cognitive Development

Start date: February 8, 2024
Phase: N/A
Study type: Interventional

The goal of this interventional study is to establish a whole food, avocado, as a viable study material to supplement mothers and infants with nutrients that support optimal brain development. Eighty-eight breastfeeding dyads, 3m postnatal, will participate in this study designed to: 1. To document whether lactating mothers will comply in the consumption of 5 avocados a week for 12 weeks. 2. To ascertain the choline, lutein, and fatty acids present in human milk in women who eat avocado. 3. To measure the cognitive advantage conferred to infants whose mothers consume avocados while breastfeeding compared to a non-avocado-eating reference group. To this end, healthy, lactating women who are 13 weeks postpartum and their infants will be enrolled. Mothers will be provided avocados on a bi-weekly basis and will be asked to consume an avocado a day. Infant cognition will be tested when the infants are 4.5 and 6 months of age. Milk samples and diet data will be collected and assayed on a bi-weekly basis.

NCT ID: NCT06207929 Recruiting - COVID-19 Clinical Trials

Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections

WAVE
Start date: January 21, 2024
Phase:
Study type: Observational

The goal of this decentralized, observational study is to enroll and observe adults in the contingent United States during the 2023-2024 flu season. The main study objectives are to create a dataset of paired wearable data, self-reported symptoms, and respiratory viral infection (RVI) from PCR testing during the 2023-2024 flu season and to develop algorithm that is able to accurately classify asymptomatic and symptomatic RVI and understand the algorithm's performance metrics.

NCT ID: NCT06207903 Not yet recruiting - Clinical trials for Mild Cognitive Impairment

Navigating the Clinical Research Process for Mild Cognitive Impairment

Start date: February 2025
Phase:
Study type: Observational

Participation in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of mild cognitive impairment patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future mild cognitive impairment patients.

NCT ID: NCT06207890 Not yet recruiting - Anorexia Nervosa Clinical Trials

Exploring Clinical Study Experiences of People With Anorexia Nervosa

Start date: February 2025
Phase:
Study type: Observational

The study seeks to delve into the firsthand experiences of patients diagnosed with anorexia nervosa who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future anorexia nervosa patients and play an active role in advancing medical research.

NCT ID: NCT06207864 Recruiting - Malignant Neoplasm Clinical Trials

Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing

PE-CGS
Start date: March 22, 2022
Phase: N/A
Study type: Interventional

This clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American Indians in the Southwest have higher rates of some types of cancer, such as cancers that arise in the liver, kidney, breast, and colon. American Indians with cancer may also live for less time than people from other population groups who have been treated for the same cancer. Damage to the cells of the body, acquired as people live, grow older, and are exposed to the environment, causes genetic changes in cells that can lead to cancer. This study may help researchers learn how these genetic changes in cells cause cancer and understand how and why cancer is arising in American Indians in the Southwest. This may help better prevent and treat cancer in the future.

NCT ID: NCT06207812 Recruiting - Mycosis Fungoides Clinical Trials

Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

Start date: January 19, 2024
Phase:
Study type: Observational

To follow up with all our participants with juvenile-onset mycosis fungoides, check on their status, and ask them or their parents about long term outcomes associated with their condition.

NCT ID: NCT06207799 Not yet recruiting - Multiple Myeloma Clinical Trials

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma

Start date: July 30, 2024
Phase: Phase 2
Study type: Interventional

To learn if giving elranatamab before and after an autologous stem cell transplant (ASTC) can help to control newly diagnosed, high-risk MM. An ASTC is a type of transplant in which a person's own stem cells are collected, preserved, and returned to them.

NCT ID: NCT06207786 Not yet recruiting - Skin Cancer Clinical Trials

Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery

Start date: May 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to compare surgical site infection rates for patients treated with Mohs micrographic surgery after bilateral nasal swab with povidone iodine versus standard treatment including the use of a standardized oral antibiotic prophylaxis protocol.